126 related articles for article (PubMed ID: 30972998)
1. Cytosine 5-hydroxymethylation regulated kit gene expression in acute myeloid leukemia.
Xue YM; Cheng HC; Wang JH; Wang W; Miao L
J Biol Regul Homeost Agents; 2019; 33(2):345-353. PubMed ID: 30972998
[TBL] [Abstract][Full Text] [Related]
2. DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia.
Rampal R; Alkalin A; Madzo J; Vasanthakumar A; Pronier E; Patel J; Li Y; Ahn J; Abdel-Wahab O; Shih A; Lu C; Ward PS; Tsai JJ; Hricik T; Tosello V; Tallman JE; Zhao X; Daniels D; Dai Q; Ciminio L; Aifantis I; He C; Fuks F; Tallman MS; Ferrando A; Nimer S; Paietta E; Thompson CB; Licht JD; Mason CE; Godley LA; Melnick A; Figueroa ME; Levine RL
Cell Rep; 2014 Dec; 9(5):1841-1855. PubMed ID: 25482556
[TBL] [Abstract][Full Text] [Related]
3. Characterization of acute myeloid leukemia based on levels of global hydroxymethylation.
Kroeze LI; Aslanyan MG; van Rooij A; Koorenhof-Scheele TN; Massop M; Carell T; Boezeman JB; Marie JP; Halkes CJ; de Witte T; Huls G; Suciu S; Wevers RA; van der Reijden BA; Jansen JH;
Blood; 2014 Aug; 124(7):1110-8. PubMed ID: 24986689
[TBL] [Abstract][Full Text] [Related]
4. 5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia.
Ahn JS; Kim HJ; Kim YK; Lee SS; Ahn SY; Jung SH; Yang DH; Lee JJ; Park HJ; Choi SH; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Michael S; Minden MD; Kim DD
Oncotarget; 2017 Jan; 8(5):8305-8314. PubMed ID: 28039446
[TBL] [Abstract][Full Text] [Related]
5. IDH2 regulates U2AF1 expression and hydroxymethylation in MDS patients.
Cheng H; Liu Y; Cheng M; Li W; Sun M; Tang Q; Ma J; Li P; Gong T
Biotechnol Genet Eng Rev; 2023 Mar; ():1-12. PubMed ID: 36942631
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical loss of 5-hydroxymethylcytosine expression in acute myeloid leukaemia: relationship to somatic gene mutations affecting epigenetic pathways.
Magotra M; Sakhdari A; Lee PJ; Tomaszewicz K; Dresser K; Hutchinson LM; Woda BA; Chen BJ
Histopathology; 2016 Dec; 69(6):1055-1065. PubMed ID: 27458708
[TBL] [Abstract][Full Text] [Related]
7. IDH1/2 Mutants Inhibit TET-Promoted Oxidation of RNA 5mC to 5hmC.
Xu Q; Wang K; Wang L; Zhu Y; Zhou G; Xie D; Yang Q
PLoS One; 2016; 11(8):e0161261. PubMed ID: 27548812
[TBL] [Abstract][Full Text] [Related]
8. The hypomethylating agent Decitabine causes a paradoxical increase in 5-hydroxymethylcytosine in human leukemia cells.
Chowdhury B; McGovern A; Cui Y; Choudhury SR; Cho IH; Cooper B; Chevassut T; Lossie AC; Irudayaraj J
Sci Rep; 2015 Apr; 5():9281. PubMed ID: 25901663
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation and hydroxymethylation patterns in acute myeloid leukemia patients with mutations in DNMT3A and IDH1/2 and their combinations.
Šestáková Š; Krejčík Z; Folta A; Cerovská E; Šálek C; Merkerová MD; Pecherková P; Ráčil Z; Mayer J; Cetkovský P; Remešová H
Cancer Biomark; 2019; 25(1):43-51. PubMed ID: 30988238
[TBL] [Abstract][Full Text] [Related]
10. Hydroxymethylation and tumors: can 5-hydroxymethylation be used as a marker for tumor diagnosis and treatment?
Xu T; Gao H
Hum Genomics; 2020 May; 14(1):15. PubMed ID: 32375881
[TBL] [Abstract][Full Text] [Related]
11. Isocitrate Dehydrogenase 2 Dysfunction Contributes to 5-hydroxymethylcytosine Depletion in Gastric Cancer Cells.
Chou NH; Tsai CY; Tu YT; Wang KC; Kang CH; Chang PM; Li GC; Lam HC; Liu SI; Tsai KW
Anticancer Res; 2016 Aug; 36(8):3983-90. PubMed ID: 27466503
[TBL] [Abstract][Full Text] [Related]
12. Age-related epigenome-wide DNA methylation and hydroxymethylation in longitudinal mouse blood.
Kochmanski J; Marchlewicz EH; Cavalcante RG; Sartor MA; Dolinoy DC
Epigenetics; 2018; 13(7):779-792. PubMed ID: 30079798
[TBL] [Abstract][Full Text] [Related]
13. Ascorbate-induced generation of 5-hydroxymethylcytosine is unaffected by varying levels of iron and 2-oxoglutarate.
Dickson KM; Gustafson CB; Young JI; Züchner S; Wang G
Biochem Biophys Res Commun; 2013 Oct; 439(4):522-7. PubMed ID: 24021282
[TBL] [Abstract][Full Text] [Related]
14. Additional mutations in IDH1/2-mutated patients with acute myeloid leukemia.
Lu J; Chen M; Hua H; Qin W; Zhang R; Lu X; Chao H
Int J Lab Hematol; 2021 Dec; 43(6):1483-1490. PubMed ID: 34270876
[TBL] [Abstract][Full Text] [Related]
15. Demethylation Status of Somatic DNA Extracted From Pituitary Neuroendocrine Tumors Indicates Proliferative Behavior.
Szabó B; Németh K; Mészáros K; Szücs N; Czirják S; Reiniger L; Rajnai H; Krencz I; Karászi K; Krokker L; Patócs A; Butz H
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32232382
[TBL] [Abstract][Full Text] [Related]
16. IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leukemia.
Ogawara Y; Katsumoto T; Aikawa Y; Shima Y; Kagiyama Y; Soga T; Matsunaga H; Seki T; Araki K; Kitabayashi I
Cancer Res; 2015 May; 75(10):2005-16. PubMed ID: 25795706
[TBL] [Abstract][Full Text] [Related]
17. 5-Hydroxymethylcytosine-mediated active demethylation is required for mammalian neuronal differentiation and function.
Stoyanova E; Riad M; Rao A; Heintz N
Elife; 2021 Dec; 10():. PubMed ID: 34919053
[TBL] [Abstract][Full Text] [Related]
18. 5-Hydroxymethylcytosine: An epigenetic mark frequently deregulated in cancer.
Kroeze LI; van der Reijden BA; Jansen JH
Biochim Biophys Acta; 2015 Apr; 1855(2):144-54. PubMed ID: 25579174
[TBL] [Abstract][Full Text] [Related]
19. Loss of 5-hydroxymethylcytosine is linked to gene body hypermethylation in kidney cancer.
Chen K; Zhang J; Guo Z; Ma Q; Xu Z; Zhou Y; Xu Z; Li Z; Liu Y; Ye X; Li X; Yuan B; Ke Y; He C; Zhou L; Liu J; Ci W
Cell Res; 2016 Jan; 26(1):103-18. PubMed ID: 26680004
[TBL] [Abstract][Full Text] [Related]
20. Classification of Acute Myeloid Leukemia by Cell-Free DNA 5-Hydroxymethylcytosine.
Shao J; Shah S; Ganguly S; Zu Y; He C; Li Z
Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
